Dermatology News

The live attenuated varicella-zoster vaccine is safe and provides “reasonable short-term” effectiveness in patients receiving TNF inhibitors for a variety of indications, according to data published in the Annals of Internal Medicine.

Oligoarticular disease occurs in 47% of patients with psoriatic arthritis and presents similarly to polyarticular disease, often affecting small joints of the hands and feet, according to data published in The Journal of Rheumatology.

Patients with immune mediated inflammatory diseases are tested for COVID-19 at a 20% higher rate than the general population, according to data published in Arthritis Care & Research.

Scars — whether from burns, injuries or other causes — can impact an individual’s life in many ways, and oftentimes these physical marks first appear in childhood.

A number of approaches and therapies may be necessary to treat cutaneous dermatomyositis, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

Spongiotic dermatitis was the most commonly reported cutaneous reaction to COVID-19 vaccination among patients who also had biopsy results available for review, according to a registry-based study.

A reminder of some common and not-so-common clinical scenarios can make every rheumatologist more capable of delivering optimal patient care, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

Clearly defining treatment targets and communicating those targets to patients is essential to optimizing outcomes in psoriatic arthritis, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

COVID-19 mortality was not increased in patients on immunosuppressive biologics, according to a study.

Steroid alternatives should be considered for patients with bullous pemphigoid, who are most likely to be treated with oral prednisolone, according to a study.